The Pennant Group Inc. Common Stock (PNTG)
Stock · NASDAQ · Health Care
$41.88as of 10/16/2026
Price chart
Active signals
PNTG Signal Track Record
How signals performed across all stocks →What PNTG's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | +0.9% | 58% | October 7, 2026 |
| Bollinger Band Breakout | 22 | +3.2% | 59% | September 16, 2026 |
| Bollinger Band Breakdown | 18 | -0.8% | 44% | August 28, 2026 |
| 200-Day Moving Average TouchActive now | 15 | -4.4% | 40% | November 17, 2025 |
| Any 20-session window (baseline) | +2.5% | 58% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PNTG
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling…
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- Employees
- 9,700
- Website
- www.pennantgroup.com/
Fundamentals
- 1-day range
- $41.47$42.36
- Market cap
- $1.36B
- P/E (trailing)
- 46.02
- P/E (forward)
- 26.21
- EPS (trailing)
- $0.91
- Dividend yield
- —
- Beta
- 1.33
- Avg. volume
- 313.1K
How The Pennant Group Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub
Forecasts
6 analyst ratings
The Pennant Group Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PNTGThe Pennant Group Inc. Common Stock$41.87▼ 0.95%Market cap $1.36BP/E 46.02$22.26$42.74
- INNVInnovAge Holding Corp. Common Stock$8.85▼ 1.45%Market cap $1.49BP/E —$3.94$12.64
- TDOCTeladoc Health Inc. Common Stock$5.67▼ 5.03%Market cap $1.21BP/E —$4.4$9.89
- USPHU.S. Physical Therapy Inc. Common Stock$85.71▼ 0.31%Market cap $1.16BP/E 39.50$58.19$93.5
- OMDAOmada Health Inc. Common Stock$17.63▼ 5.57%Market cap $1.16BP/E 265.49$10.28$26.92
- LFMDPLifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock$22.18▲ 0.81%Market cap $1.12BP/E 589.89$2.36$6.53
- AHCOAdaptHealth Corp. Common Stock$6.02▼ 5.79%Market cap $824.20MP/E —$5.21$13.43
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PNTG The Pennant Group Inc. Common Stock | $1.36B | 46.02 | $41.87 | ▼ 0.95% | $22.26$42.74 |
| INNV InnovAge Holding Corp. Common Stock | $1.49B | — | $8.85 | ▼ 1.45% | $3.94$12.64 |
| TDOC Teladoc Health Inc. Common Stock | $1.21B | — | $5.67 | ▼ 5.03% | $4.4$9.89 |
| USPH U.S. Physical Therapy Inc. Common Stock | $1.16B | 39.50 | $85.71 | ▼ 0.31% | $58.19$93.5 |
| OMDA Omada Health Inc. Common Stock | $1.16B | 265.49 | $17.63 | ▼ 5.57% | $10.28$26.92 |
| LFMDP LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock | $1.12B | 589.89 | $22.18 | ▲ 0.81% | $2.36$6.53 |
| AHCO AdaptHealth Corp. Common Stock | $824.20M | — | $6.02 | ▼ 5.79% | $5.21$13.43 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 3 Cash-Producing Stocks We Steer Clear OfYahoo · 10/7/2026
- 2 Healthcare Stocks to Target This Week and 1 We AvoidYahoo · 9/28/2026
- Pennant Group (PNTG) Acquires Mainplace Senior Living Real Estate in OrangeYahoo · 9/25/2026
- 1 Growth Stock with All-Star Potential and 2 We Find RiskyYahoo · 9/24/2026
- Are You Looking for a Top Momentum Pick? Why The Pennant Group, Inc. (PNTG) is a Great ChoiceYahoo · 9/21/2026
- The Pennant Group: The Pros Of Investing Continue To Outweigh The ConsSeekingAlpha · 9/18/2026
- The Pennant Group (PNTG) Moves 6.3% Higher: Will This Strength Last?Yahoo · 9/17/2026
- Pennant Acquires Real Estate of Mainplace Senior Living in Orange, CaliforniaYahoo · 9/16/2026
Insider Activity
Insider Actions →- Cheney Kirk Sterling · August 6, 2026 · Sale1.4K @ $38.52
- Steik Jason Paul · August 6, 2026 · Sale1.4K @ $38.52
- Guerisoli Brent · August 6, 2026 · Sale4.3K @ $38.52
- Morris Gregory K Sr. · July 15, 2026 · Grant1.9K
- Suzanne D. Snapper · July 15, 2026 · Grant1.9K
- Nackel John G. · July 15, 2026 · Grant1.9K
- Christensen Christopher R. · July 15, 2026 · Grant1.9K
- Lamb Scott E · July 15, 2026 · Grant2.4K
- Barry M. Smith · July 15, 2026 · Grant1.9K
- COVEY STEPHEN M R · July 15, 2026 · Grant1.9K
- Guerisoli Brent · July 10, 2026 · Option Exercise6.2K @ $4.54
- Guerisoli Brent · July 10, 2026 · Sale3.2K @ $41.57
- Guerisoli Brent · July 7, 2026 · Option Exercise6.2K @ $4.54
- Guerisoli Brent · July 7, 2026 · Sale3.2K @ $40.51
- Guerisoli Brent · May 22, 2026 · Option Exercise4.5K @ $3.84
Institutional Ownership
March 31, 2026
- Total shares held
- 28.97M
- Total value held
- $799.43M
- Institutional holders
- 184
- Unknown2.72M
- Unknown2.67M
- Unknown1.58M
- Unknown1.42M
- Unknown1.41M
- Unknown1.10M
- Unknown983.0K
- Unknown903.9K
- Unknown872.2K
- Unknown842.1K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pennant Group Featured in Cash-Flow Stock List
The Pennant Group was included in a recent Yahoo Finance article titled '3 Cash-Producing Stocks We Steer Clear Of.' This inclusion highlights the company's cash flow characteristics as a point of discussion among investors. The stock currently trades within its 52-week range, with an average analyst target price of $46.83.
Pennant Group Featured in Cash-Flow Stock List. The Pennant Group was included in a recent Yahoo Finance article titled '3 Cash-Producing Stocks We Steer Clear Of.' This inclusion highlights the company's cash flow characteristics as a point of discussion among investors. The stock currently trades within its 52-week range, with an average analyst target price of $46.83.